Evidence map›Paper›PMID 40122138›Full record

ArticlePathogens and global health

Epidemiological landscape in a Mediterranean hotspot of human leishmaniosis in Spain under a One Health approach.

Jesús Barbero-Moyano, Moisés Gonzálvez, Daniel Bravo-Barriga, Ignacio García-Bocanegra, Pedro López-López, Antonio Rivero-Juárez, Francisco Ruiz-Fons, Inmaculada Moreno, Antonio J Carpio, Remigio Martínez and 4 more

Abstract read
In one paragraph

Article in Pathogens and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. International journal for parasitology. Parasites and wildlife · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jesús Barbero-MoyanoDepartamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, Spain.
Moisés GonzálvezDepartamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, Spain.ORCID 0000-0003-0423-3189
Daniel Bravo-BarrigaDepartamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, Spain.
Ignacio García-BocanegraDepartamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, Spain.
Pedro López-LópezCIBERINFEC, ISCIII CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Antonio Rivero-JuárezCIBERINFEC, ISCIII CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Francisco Ruiz-FonsSaBio (Health and Biotechnology) Group, Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ciudad Real, Spain.
Inmaculada MorenoUnidad de Inmunología Microbiana, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
Antonio J CarpioDepartment of Zoology, University of Cordoba, Cordoba, Spain.
Remigio MartínezDepartamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, Spain.
Ana Belén PérezCIBERINFEC, ISCIII CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
María Angustias JiménezCentro de Transfusión, Tejidos y Células, Córdoba, Spain.
Antonio RiveroCIBERINFEC, ISCIII CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
María Ángeles RisaldeCIBERINFEC, ISCIII CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrated One Health studies are essential to assess the potential risks associated with leishmaniosis hotspots in Europe. Thus, the aim was to holistically evaluate

Indexed as

Leishmania infantumLeishmaniasisLeishmaniasis, VisceralOne HealthAnimalsDog DiseasesDogsFemaleHumansInsect VectorsMalePhlebotomusPhylogenyPsychodidaeSpainDoghotspothumanLeishmaniasandflywild lagomorphs

Identifiers

PMID40122138
PMCPMC12086916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.